Atlas Trials

A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and Artesunate

Clinical trial NCT05929157 · UNKNOWN

Trial details

NCT number
NCT05929157
Sponsor
Centre de Recherche Médicale de Lambaréné
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Severe Malarial Treatment
Start date
2023-09-01
Primary completion
2024-12-31
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.